Failure of immunotherapy in high-grade serous ovarian cancer (HGSC) may be due to high levels of transforming growth factor-β (TGF-β) in ascites or tumour immune microenvironment (TIME). Here, we test ...
In a recent study posted in the Research Square* preprint server, which is under consideration at a Nature Portfolio Journal, researchers evaluated the pathogenicity and replication potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results